{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:58:18Z","timestamp":1790701098251,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["PVS-0215 00099.01.00\/23"],"award-info":[{"award-number":["PVS-0215 00099.01.00\/23"]}],"id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405934\/2022-0"],"award-info":[{"award-number":["405934\/2022-0"]}],"id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310826\/2020-9"],"award-info":[{"award-number":["310826\/2020-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305003\/2022-4"],"award-info":[{"award-number":["305003\/2022-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405312\/2021-0"],"award-info":[{"award-number":["405312\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["307745\/2025-2"],"award-info":[{"award-number":["307745\/2025-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.837965\/2023-00"],"award-info":[{"award-number":["88887.837965\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.micpath.2025.107701","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T23:06:26Z","timestamp":1747091186000},"page":"107701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of 5-fluorouracil on Escherichia coli and Enterococcus spp.: insights into the selective pressures caused by this cytotoxic drug"],"prefix":"10.1016","volume":"206","author":[{"given":"Expedito Maia","family":"Di\u00f3genes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Pantoja","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson Lucena","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius Carvalho","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Roberto Hon\u00f3rio","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Victor Coelho","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo C\u00e9sar Pereira","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Filho Noronha","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos F\u00e1bio Gadelha","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J\u00falio Costa","family":"Sidrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana de Aguiar","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00e1ucia Morgana de Melo","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Carvalho","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora de Souza Collares Maia","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.107701_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.micpath.2025.107701_bib2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules13081551","article-title":"5-Fluorouracil: mechanisms of resistance and reversal strategies","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2025.107701_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s13402-020-00529-1","article-title":"Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update","volume":"43","author":"Xie","year":"2020","journal-title":"Cell. Oncol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107701_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.micpath.2025.107701_bib5","article-title":"Adverse effects of 5-fluorouracil: focus on rare side effects","volume":"3","author":"Thomas","year":"2016","journal-title":"Cancer Cell Microenviron."},{"key":"10.1016\/j.micpath.2025.107701_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-019-0679-5","article-title":"Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis","volume":"7","author":"Hong","year":"2019","journal-title":"Microbiome"},{"issue":"3","key":"10.1016\/j.micpath.2025.107701_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bcpt.12793","article-title":"Apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of 5\u2010fluorouracil\u2010induced intestinal mucositis in mice","volume":"121","author":"Hamouda","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107701_bib8","doi-asserted-by":"crossref","DOI":"10.1034\/j.1399-302X.2003.00075.x","article-title":"Oral and intestinal microflora in 5\u2010fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria","volume":"18","author":"Von B\u00fcltzingsl\u00f6wen","year":"2003","journal-title":"Oral Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107701_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/AAC.17.3.417","article-title":"Bioassay of antibiotics in body fluids from patients receiving cancer chemotherapeutic agents","volume":"17","author":"Wright","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2025.107701_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/AAC.23.3.374","article-title":"Interactions of beta-lactam antibiotics and antineoplastic agents","volume":"23","author":"Ueda","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2025.107701_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.28.3.437","article-title":"Antibacterial activities of antineoplastic agents","volume":"28","author":"Bodet","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.micpath.2025.107701_bib12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.7164\/antibiotics.39.1167","article-title":"Enhancement of 5-fluorouracil uptake into the bacterial cell by piperacillin","volume":"39","author":"Takahata","year":"1986","journal-title":"J. Antibiot."},{"issue":"8","key":"10.1016\/j.micpath.2025.107701_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1099\/jmm.0.000292","article-title":"5-Fluorouracil sensitivity varies among oral micro-organisms","volume":"65","author":"Vanlancker","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107701_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cotox.2023.100423","article-title":"Gut microbiota: impact on 5-fluorouracil efficacy and toxicity","author":"Lo","year":"2023","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.micpath.2025.107701_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2019.02.020","article-title":"Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota","volume":"80","author":"Sougiannis","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.micpath.2025.107701_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3002(60)91311-1","article-title":"Metabolism of uracil and 5-fluorouracil by drug-sensitive and by drug-resistant bacteria","volume":"40","author":"Brockman","year":"1960","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.micpath.2025.107701_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3181\/0810-RM-301","article-title":"Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis","volume":"234","author":"Stringer","year":"2009","journal-title":"Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.micpath.2025.107701_bib18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/antibiotics13060528","article-title":"Deciphering the antibacterial mechanisms of 5-fluorouracil in Escherichia coli through biochemical and transcriptomic analyses","volume":"13","author":"Zhang","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micpath.2025.107701_bib19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1186\/s12885-021-09054-2","article-title":"Gut microbiome and its role in colorectal cancer","volume":"21","author":"Rebersek","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.micpath.2025.107701_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biopha.2018.08.165","article-title":"The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer","volume":"108","author":"Yuan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2025.107701_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103742","article-title":"The chemotherapeutic drug methotrexate selects for antibiotic resistance","volume":"74","author":"Gu\u00f0mundsd\u00f3ttir","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.micpath.2025.107701_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1751-7915.2008.00060.x","article-title":"Uracil influences quorum sensing and biofilm formation in Pseudomonas aeruginosa and fluorouracil is an antagonist","volume":"2","author":"Ueda","year":"2009","journal-title":"Microb. Biotechnol."},{"issue":"13","key":"10.1016\/j.micpath.2025.107701_bib23","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1093\/nar\/gkab251","article-title":"5-Fluorouracil blocks quorum-sensing of biofilm-embedded methicillin-resistant Staphylococcus aureus in mice","volume":"49","author":"Sedlmayer","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2025.107701_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jia.2024.07.007","article-title":"Targeting ThyA: investigating the mechanisms of 5-FU-induced inhibition of biofilm formation and virulence in Streptococcus suis through LuxS\/AI-2 quorum sensing","author":"Zuo","year":"2024","journal-title":"J. Integr. Agric."},{"issue":"1","key":"10.1016\/j.micpath.2025.107701_bib25","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1002\/cpcy.72","article-title":"Estimation of microbial viability using flow cytometry","volume":"93","author":"Davey","year":"2020","journal-title":"Curr. Protoc. Cytom."},{"issue":"4","key":"10.1016\/j.micpath.2025.107701_bib26","first-page":"870","article-title":"Studying antimicrobial-induced morphostructural damage of bacteria by Scanning Electron Microscope, Bangladesh J","volume":"10","author":"Shukla","year":"2015","journal-title":"Pharmacol."},{"key":"10.1016\/j.micpath.2025.107701_bib27","series-title":"Encyclopedia of Rapid Microbiological Methods","first-page":"1","article-title":"Microbial identification using the bioM\u00e9rieux Vitek\u00ae 2 system","author":"Pincus","year":"2006"},{"key":"10.1016\/j.micpath.2025.107701_bib28","series-title":"Performance Standards for Antimicrobial Susceptibility Testing, CLSI Supplement M100-S27","year":"2020"},{"issue":"12","key":"10.1016\/j.micpath.2025.107701_bib29","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2217\/fmb-2020-0010","article-title":"Rhamnolipid enhances Burkholderia pseudomallei biofilm susceptibility, disassembly and production of virulence factors","volume":"15","author":"Sidrim","year":"2020","journal-title":"Future Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107701_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10482-023-01812-5","article-title":"Virulence factors of Gram-negative bacteria from free-ranging Amazon river dolphins (Inia geoffrensis)","volume":"116","author":"Rocha","year":"2023","journal-title":"Antonie Leeuwenhoek"},{"issue":"2","key":"10.1016\/j.micpath.2025.107701_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-7012(00)00122-6","article-title":"A modified microtiter-plate test for quantification of staphylococcal biofilm formation","volume":"40","author":"Stepanovi\u0107","year":"2000","journal-title":"J. Microbiol. Methods"},{"issue":"12","key":"10.1016\/j.micpath.2025.107701_bib32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2217\/fmb-2019-0092","article-title":"Chlorpromazine-impregnated catheters as a potential strategy to control biofilm-associated urinary tract infections","volume":"14","author":"Sidrim","year":"2019","journal-title":"Future Microbiol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107701_bib33","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/microorganisms11071641","article-title":"Microbial growth under limiting conditions\u2014future perspectives","volume":"11","author":"Gonzalez","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2025.107701_bib34","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10529-016-2079-2","article-title":"Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants","volume":"38","author":"Elshikh","year":"2016","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.micpath.2025.107701_bib35","first-page":"3","article-title":"Measuring cell viability by resazurin (Alamarblue\u00ae) assay using Photopette\u00ae Cell","author":"Lee","year":"2017","journal-title":"Appl. Note Tip Biosyst. Cell Viability Life Sci."},{"key":"10.1016\/j.micpath.2025.107701_bib36","series-title":"Chaperones: Methods Protoc","first-page":"107","article-title":"Cell death and survival assays","author":"Kabakov","year":"2018"},{"key":"10.1016\/j.micpath.2025.107701_bib37","article-title":"Synthesis, molecular docking, and biological activity of thioether derived from juglone in preclinical models of chronic myeloid leukemia","volume":"20","author":"Portilho","year":"2021","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.micpath.2025.107701_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116256","article-title":"Antitumoral effect of novel synthetic 8-hydroxy-2-((4-nitrophenyl) thio) naphthalene-1, 4-dione (CNN16) via ROS-mediated DNA damage, apoptosis and anti-migratory effect in colon cancer cell line","volume":"456","author":"da Silva","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107701_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ijbiomac.2020.10.220","article-title":"Essential oils encapsulated in chitosan microparticles against Candida albicans biofilms","volume":"166","author":"Garcia","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107701_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028654","article-title":"Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing, and PCR-DGGE fingerprinting","volume":"6","author":"Zwielehner","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2025.107701_bib41","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00520-013-1741-7","article-title":"Biomarkers of chemotherapy-induced diarrhea: a clinical study of intestinal microbiome alterations, inflammation, and circulating matrix metalloproteinases","volume":"21","author":"Stringer","year":"2013","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.micpath.2025.107701_bib42","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00248-013-0355-4","article-title":"16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation","volume":"67","author":"Montassier","year":"2014","journal-title":"Microb. Ecol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107701_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/AAC.1.4.348","article-title":"Effect of chemotherapeutic agents upon microorganisms isolated from cancer patients","volume":"1","author":"Goldschmidt","year":"1972","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.107701_bib44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/599346","article-title":"Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut","volume":"49","author":"van Vliet","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.micpath.2025.107701_bib45","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1021\/acsomega.9b03695","article-title":"Small-molecule inhibition of bacterial biofilm","volume":"5","author":"Ghosh","year":"2020","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.micpath.2025.107701_bib46","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3390\/microorganisms12112257","article-title":"5-Fluorouracil inhibits bacterial growth and reduces biofilm in addition to having synergetic effects with gentamicin against Pseudomonas aeruginosa","volume":"12","author":"Niazy","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2025.107701_bib47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00253-009-1860-8","article-title":"5-Fluorouracil reduces biofilm formation in Escherichia coli K-12 through global regulator AriR as an antivirulence compound","volume":"82","author":"Attila","year":"2009","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107701_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41579-022-00791-0","article-title":"The biofilm matrix: multitasking in a shared space","volume":"21","author":"Flemming","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2025.107701_bib49","first-page":"3","article-title":"Inhibition of quorum-sensing: a new paradigm in controlling bacterial virulence and biofilm formation","author":"Ivanova","year":"2018","journal-title":"Biotechnol. Appl. Quorum Sens. Inhib."},{"key":"10.1016\/j.micpath.2025.107701_bib50","article-title":"The antimycotic 5-fluorocytosine is a virulence inhibitor of uropathogenic Escherichia coli and eradicates biofilm-embedded bacteria synergizing with \u03b2-lactams","author":"Ravishankar","year":"2024","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.micpath.2025.107701_bib51","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/rcm.3362","article-title":"Quantitation of 5\u2010fluorouracil (5\u2010FU) in human plasma by liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"22","author":"Kosovec","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.micpath.2025.107701_bib52","article-title":"Administration mode matters for 5\u2010fluorouracil therapy: physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus","author":"Chao","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107701_bib53","article-title":"Association of bacterial infection, resistance of antibiotic and cancer chemotherapy: an escalating threat in cancer treatment","volume":"13","author":"Sonowal","year":"2024","journal-title":"Int. J. Sci. Res."},{"key":"10.1016\/j.micpath.2025.107701_bib54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1134\/S0026893317050077","article-title":"Increase in bacterial resistance to antibiotics after cancer therapy with platinum-based drugs","volume":"52","author":"Chistyakov","year":"2018","journal-title":"Mol. Biol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107701_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.26443\/msurj.v18i1.190","article-title":"Bacterial interactions affecting chemotherapy effectiveness","volume":"18","author":"Chambers","year":"2023","journal-title":"McGill Sci. Undergrad. Res. J."},{"issue":"5","key":"10.1016\/j.micpath.2025.107701_bib56","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/bi00869a025","article-title":"Ribosome synthesis in Escherichia coli treated with 5-fluorouracil","volume":"5","author":"Hills","year":"1966","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.micpath.2025.107701_bib57","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/s41564-022-01226-5","article-title":"Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism","volume":"7","author":"Spanogiannopoulos","year":"2022","journal-title":"Nat. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107701_bib58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","article-title":"Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy","volume":"164","author":"Chrysostomou","year":"2023","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.micpath.2025.107701_bib59","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1073\/pnas.46.3.324","article-title":"The mechanism of bacterial fragility produced by 5-fluorouracil: the accumulation of cell wall precursors","volume":"46","author":"Tomasz","year":"1960","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"3629","key":"10.1016\/j.micpath.2025.107701_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.145.3629.276","article-title":"Uracil: failure to restore DNA synthesis while relieving 5-fluorouracil-induced inhibition","volume":"145","author":"Reich","year":"1964","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.micpath.2025.107701_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300103","article-title":"Synthesis and antimicrobial testing of 5\u2010fluorouracil derivatives","volume":"356","author":"Patil","year":"2023","journal-title":"Arch. Pharm."},{"issue":"8","key":"10.1016\/j.micpath.2025.107701_bib62","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1021\/acs.jmedchem.6b01243","article-title":"Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria","volume":"60","author":"Dharmaraja","year":"2017","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.micpath.2025.107701_bib63","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1128\/JB.00389-15","article-title":"Loss of antibiotic tolerance in Sod-deficient mutants is dependent on the energy source and arginine catabolism in enterococci","volume":"197","author":"Ladjouzi","year":"2015","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2025.107701_bib64","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10495-017-1424-9","article-title":"Induction of reactive oxygen species: an emerging approach for cancer therapy","volume":"22","author":"Zou","year":"2017","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.micpath.2025.107701_bib65","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1002\/jcp.26356","article-title":"Reactive oxygen species and colorectal cancer","volume":"233","author":"Lin","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107701_bib66","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.celrep.2015.09.059","article-title":"Bactericidal antibiotics induce toxic metabolic perturbations that lead to cellular damage","volume":"13","author":"Belenky","year":"2015","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.micpath.2025.107701_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4062\/biomolther.2022.017","article-title":"Modulation of reactive oxygen species to overcome 5-fluorouracil resistance","volume":"30","author":"Chun","year":"2022","journal-title":"Biomol. Ther."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025004267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025004267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T18:50:13Z","timestamp":1752000613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025004267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":67,"alternative-id":["S0882401025004267"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107701","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of 5-fluorouracil on Escherichia coli and Enterococcus spp.: insights into the selective pressures caused by this cytotoxic drug","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107701"}}